2017
DOI: 10.3126/ijssm.v4i2.16684
|View full text |Cite
|
Sign up to set email alerts
|

Monkeypox Transmission, Need and Treatment of Humans with an Antiviral Drug

Abstract: Monkeypox is a viral zoonotic disease belongs to the family Poxviridae and Orthopoxvirus genus. Transmission of monkey pox is through direct contact with infected animal and blood. Human to human transmission occur through respiratory route but previously so many studies are conducted to prove that monkey pox viruse was not transmitted through the respiratory route both in animals and humans. But now monkey pox is able to survive in humans due to genetic changes and human to human transmission is possible. Bec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 12 publications
0
4
0
Order By: Relevance
“…At the time of this review, there was no definitive evidence that antivirals were effective for treating monkeypox in humans, but since they are effective in treating animals, they are also expected to be effective in treating humans ( 6 , 165 , 166 ). Although there are no monkeypox-specific antivirals, antivirals such as brincidofovir and tecovirimat can be used to treat monkeypox ( 5 , 167 ). Tecovirimat is safe to be used in the early stages of the infection, and if treatment is initiated during the incubation period it can prevent overt clinical presentations ( 168 , 169 ).…”
Section: Treatmentmentioning
confidence: 99%
“…At the time of this review, there was no definitive evidence that antivirals were effective for treating monkeypox in humans, but since they are effective in treating animals, they are also expected to be effective in treating humans ( 6 , 165 , 166 ). Although there are no monkeypox-specific antivirals, antivirals such as brincidofovir and tecovirimat can be used to treat monkeypox ( 5 , 167 ). Tecovirimat is safe to be used in the early stages of the infection, and if treatment is initiated during the incubation period it can prevent overt clinical presentations ( 168 , 169 ).…”
Section: Treatmentmentioning
confidence: 99%
“…Since monkeypox virus and vaccinia virus are genetically related, medications effective on smallpox might also be beneficial in managing monkeypox. Antivirals suggested to defend against monkeypox include brincidofovir and tecovirimat (Jabeen & Umbreen, 2017). Brincidofovir (CMX001), a lipophilic conjugate of cidofovir with less toxicity, is an oral DNA polymerase inhibitor with anti-poxvirus activity (Hutson et al, 2021).…”
Section: Treatmentmentioning
confidence: 99%
“…However, CDC recommends consideration of cidofovir in individuals with severe monkeypox infection; brincidofovir has an improved safety profile over cidofovir as it has less renal toxicity during its use in the treatment of cytomegalovirus infection. Tecovirimat (previously known as ST-246) is an oral antiviral agent with activity against orthopoxviruses including monkeypox in vitro and in animal studies but its effectiveness in humans is unknown (24).…”
Section: Case Managementmentioning
confidence: 99%